Mr. Wenhui Wang | Macrophage | Best Researcher Award

Posted on by Pencis

Mr. Wenhui Wang | Macrophage | Best Researcher Award

The First Affiliated Hospital of Dalian Medical University | China

AUTHOR PROFILE

Scopus

📚EARLY ACADEMIC PURSUITS 

Wenhui wang’s academic journey began with a strong foundation in medical imaging, completing a bachelor’s degree in medical imaging at shanxi medical university fenyang college in 2021. He then pursued a master’s in radiological imaging at shanxi medical university, graduating in july 2024. His dedication to advancing medical imaging continues with his current ph.d. Study in imaging medicine and nuclear medicine at dalian medical university, where he is engaged in cutting-edge research.

🧑‍🔬PROFESSIONAL ENDEAVORS 

Wenhui wang has embarked on a promising research career in the field of medical imaging and radiological science, particularly focused on macrophage tracking, stem cell imaging, and the development of advanced imaging probes. He is a principal investigator for several significant research projects in shanxi, including the development of new contrast agents for dynamic studies and the study of molecular imaging in the diagnosis and assessment of osteogenic and chondrogenic tumors like osteosarcoma and chondrosarcoma.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON MACROPHAGE 

His research interests span a range of innovative topics, including macrophage tracking imaging, stem cell repair of osseocartilaginous defects, and the application of imaging for the diagnosis of traumatic and tumorous lesions in bones and joints. He is particularly interested in understanding the role of nano-molecular probes and developing novel imaging agents to improve diagnosis and treatment predictions in oncology and infectious diseases.

IMPACT AND INFLUENCE 🌍

Wenhui wang’s research has the potential to significantly impact the fields of radiological imaging, medical diagnostics, and stem cell research. His work in the development of nano-probes for molecular imaging could lead to advancements in the early diagnosis of cancer and improve the understanding of tumor behavior. Additionally, his study of stem cell therapy and cartilage repair could open new avenues in regenerative medicine.

AWARDS AND HONORS 🏅

Wang has received several academic awards for his exceptional performance and contributions to the field, including the master’s national scholarship, multiple university-level prizes, and recognition in competitions like the zhongqing cup national college student mathematical modeling competition. These awards reflect his outstanding academic achievements and dedication to excellence.

ACADEMIC CITES AND RECOGNITION 📜

Wang’s research has garnered increasing attention in the field of medical imaging, particularly through his pioneering studies in the application of technologies in tumor diagnosis and stem cell repair. His work is expected to contribute to future clinical practices and influence future research directions in the medical imaging community.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Wenhui wang is set to leave a lasting legacy in the fields of radiological imaging and stem cell therapy. His innovative research on advanced imaging agents and stem cell interventions could not only improve the diagnosis and treatment of cancer and bone diseases but also pave the way for new clinical applications in regenerative medicine. His future work has the potential to transform the way we approach medical imaging and treatment predictions.

🔗 CONCLUSION

Wenhui Wang is an emerging talent in the fields of medical imaging and nuclear medicine, with a strong foundation in radiological imaging and a forward-thinking research agenda. His work, focusing on macrophage tracking, stem cell therapy, and the development of novel imaging probes, positions him at the forefront of medical imaging advancements. Through his groundbreaking research, he has already demonstrated significant contributions to the understanding and treatment of osteogenic and chondrogenic tumors, as well as the enhancement of cartilage repair techniques.

📊🔬NOTABLE PUBLICATION:
  • Prognostic Factors and Surgical Impact of Non-metastatic Conventional Chondrosarcoma of the Extremities
    • Authors: Wang, W., Zhen, J.
    • Journal: Orthopaedic Surgery
    • Year: 2023

 

  • MRI Radiomics-based Evaluation of Tuberculous and Brucella Spondylitis
    • Authors: Wang, W., Fan, Z., Zhen, J.
    • Journal: Journal of International Medical Research
    • Year: 2023

Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Posted on by Pencis

Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Yueyang Central Hospital | China

AUTHOR PROFILE

ORCID ID

📚EARLY ACADEMIC PURSUITS 

ZENG QINGJUN completed his Master’s degree at Xiangya Medical College, Central South University, in 2010. This prestigious institution provided a strong foundation in medical education, equipping him with the skills and knowledge necessary for his future in the field of gastrointestinal surgery. His academic training allowed him to develop expertise in complex surgical techniques, laying the groundwork for his career as a clinical specialist in surgery.

⚕️PROFESSIONAL ENDEAVORS 

Since July 2010, ZENG QINGJUN has been working in the field of gastrointestinal surgery, focusing on laparoscopic techniques for treating gastric and colorectal cancers. As a chief physician, he plays a pivotal role in leading surgical teams, performing high-risk surgeries, and making critical decisions for patient care. His clinical expertise and skillful handling of over 200 laparoscopic gastric cancer surgeries and 400 laparoscopic colorectal cancer surgeries are testaments to his proficiency in minimally invasive surgical methods. His surgical outcomes have contributed significantly to improving the quality of life for cancer patients and are recognized within the medical community.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON GASTROINTESTINAL TUMORS

Dr. ZENG has dedicated much of his professional life to the development and refinement of laparoscopic surgical techniques in the treatment of gastrointestinal cancers. His research is heavily focused on advancing minimally invasive surgery, particularly in the areas of gastric cancer and colorectal cancer. Through clinical trials and innovative methodologies, he has been involved in optimizing surgical procedures to ensure better postoperative recovery, reduced complications, and more efficient treatment pathways for cancer patients.

🌍IMPACT AND INFLUENCE 

Dr. ZENG QINGJUN has made an immense impact on the practice of gastrointestinal surgery in China, particularly in the realm of laparoscopic surgery. His innovative approaches and commitment to cutting-edge techniques have influenced both local and national surgical practices. His contribution to gastric and colorectal cancer surgery has improved patient outcomes and has set new standards in the field. As a chief physician, he mentors younger surgeons and shares his expertise, ensuring the continued progress of surgical techniques.

📑ACADEMIC CITATIONS 

While detailed citation metrics are not provided, Dr. ZENG’s extensive clinical experience and research endeavors have led to his recognition in academic circles. His focus on laparoscopic techniques and cancer surgery continues to influence current and future generations of surgeons and researchers in the field. His work, particularly in gastric and colorectal cancer, has made notable contributions to medical literature and has been referenced in various academic and clinical studies.

🌱LEGACY AND FUTURE CONTRIBUTIONS 

Dr. ZENG QINGJUN’s career reflects a legacy of excellence in surgical practice and medical innovation. His pioneering work in laparoscopic surgery and cancer treatment has already set the stage for future breakthroughs in the field of gastrointestinal oncology. Looking forward, he is likely to contribute even more significantly to surgical research, possibly expanding his focus to robot-assisted surgeries, postoperative care advancements, and the integration of AI in surgical planning. His mentorship, both locally and nationally, will shape the future of surgical education and the next generation of gastrointestinal surgeons.

💼LEADERSHIP IN SURGICAL PRACTICE 

Dr. ZENG continues to hold a significant leadership role in the surgical department at his medical institution. His capacity as chief physician enables him to make high-level decisions in clinical practice, direct surgical teams, and implement best practice guidelines. His strategic leadership in gastrointestinal surgery helps to establish protocols for laparoscopic surgeries, improving surgical outcomes, and pushing the boundaries of traditional approaches.

🔗 CONCLUSION

Dr. Zeng Qingjun is a distinguished gastrointestinal surgeon whose work has significantly advanced the field of laparoscopic surgery for gastric and colorectal cancers. With over a decade of experience and hundreds of successful surgeries, his contributions have set new standards in minimally invasive surgical techniques, improving patient outcomes and recovery times. Through his leadership as chief physician, he has not only influenced clinical practices but has also become a mentor to aspiring surgeons, ensuring the continuity of high-quality surgical education.

📊🔬NOTABLE PUBLICATION:
  • 1. Title: Knockdown of BUB1B Inhibits the Proliferation, Migration, and Invasion of Colorectal Cancer by Regulating the JNK/c-Jun Signaling Pathway
    Authors: Qingjun Zeng, Sanjun Zhang, Linfang He, Qingyan Fu, Li Liao, Linjie Chen, Xiang Ding
    Journal: Cancer Biotherapy and Radiopharmaceuticals
    Year: 2023

    2. Title: Targeting of MAD2L1 by miR‐515‐5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells
    Authors: Xiang Ding, Qingyan Fu, Weixing Chen, Linjie Chen, Qingjun Zeng, Sanjun Zhang, Linfang He
    Journal: Cell Biology International
    Year: 2022

Prof. Ming-Yow Hung | Cardio-Oncology | Best Researcher Award

Posted on by Pencis

Prof. Ming-Yow Hung | Cardio-Oncology | Best Researcher Award

Taipei Medical University | Taiwan

Author Profile

Scopus

ORCID ID

Biography: Prof. Ming-Yow Hung, MD, PhD 🌟💖🩺

Name: Prof. Ming-Yow Hung
Citizenship: Taiwanese

🎓 Education:

  • Medical Degree: School of Medicine, College of Medicine, Chang Gung University (1989–1995).
  • PhD: Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine (2007–2017).

🎖 Military Service:

  • Lieutenant General Physician, Navy, Taiwan, Republic of China (1996–1998).

💼 Professional Roles:

  • Attending Cardiologist: Division of Cardiology, Shuang Ho Hospital, Taipei Medical University (2008–present).
  • Professor of Medicine: Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University (since 2022).

🏅 Board Certifications:

  • Internal Medicine (2001).
  • Adult Cardiology (2004).

🔬 Research Interests:

  • Interventional Cardiology
  • Echocardiography
  • Basic Cardiovascular Science

📜 Editorial Contributions:

  • Editorial Board Member:

    • Enliven: Clinical Cardiology and Research (2015–present).
    • Journal of Epidemiological Research (2015–present).
    • SM Vascular Medicine (2015–present).

  • Guest Editor:

    • Journal of Interventional Cardiology (2019–2020).
    • Oxidative Medicine and Cellular Longevity (2023).
    • Frontiers in Cardiovascular Medicine (2023).
    • Life (2023).

🎯 Research Projects:

  1. Investigating macrophage polarization in coronary artery spasm using CRISPR core facilities (2020–2021).
  2. Mechanisms of Garcinol as α-7nAChRs Inhibitor in cardiac damage (2021–2022).
  3. LPCAT4/GDE7 axis as therapeutic targets in coronary artery spasm (2022–2023).
  4. SCAP/SREBPs signaling in lipoprotein(a)-induced macrophage polarization (2023–2026).

🌟 Professional Affiliations:

  • Fellow, American Heart Association (2013–present).
  • Fellow, American College of Cardiology (2014–present).
  • Member of multiple Taiwanese and international cardiology societies.

🏆 Honors and Awards:

  • Clinical Medicine Research Award, Taipei Medical University (2014, 2015).
  • Recognition for outstanding contributions to cardiovascular research and patient care.

Prof. Hung is renowned for his dedication to advancing cardiovascular science, particularly in coronary artery spasm and interventional cardiology. 🌍❤️

🔗 CONCLUSION

Prof. Ming-Yow Hung is a distinguished cardiologist and academic leader, whose expertise in interventional cardiology, echocardiography, and cardiovascular science has earned him national and international recognition. As a Full Professor at Taipei Medical University and a Fellow of esteemed cardiology organizations, he has made significant contributions to both clinical practice and research.

📊🔬NOTABLE PUBLICATION:
  • Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory α 7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm
    • Authors: Lin, Y.-K.; Yeh, C.-T.; Kuo, K.-T.; Hu, P.; Hung, M.-Y.
    • Journal: Oxidative Medicine and Cellular Longevity
    • Year: 2022

 

  • The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review
    • Authors: Karimabad, M.N.; Kounis, N.G.; Hassanshahi, G.; Hung, M.-Y.; Nadimi, A.E.
    • Journal: Vaccines
    • Year: 2021

 

  • The Effect of Long COVID-19 Infection and Vaccination on Male Fertility: A Narrative Review
    • Authors: Pourmasumi, S.; Nazari, A.; Ahmadi, Z.; Altay, S.; Kounis, N.G.
    • Journal: Vaccines
    • Year: 2022

 

  • “When,” “Where,” and “How” of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review
    • Authors: Kounis, N.G.; Gogos, C.; de Gregorio, C.; Velissaris, D.; Koniar, I.
    • Journal: Balkan Medical Journal
    • Year: 2024

 

  • Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review
    • Authors: Hung, M.-J.; Yeh, C.-T.; Kounis, N.G.; Hu, P.; Hung, M.-Y.
    • Journal: International Journal of Molecular Sciences
    • Year: 2023

Assist. Prof. Dr. Ting Zhu | Pharmaco-Oncology | Best Researcher Award

Posted on by Pencis

Assist. Prof. Dr. Ting Zhu | Pharmaco-Oncology | Best Researcher Award

Qingdao University | China

AUTHOR PROFILE

Scopus

ORCID ID

🧩 EARLY ACADEMIC PURSUITS

Dr. Ting Zhu’s academic journey began with a strong foundation in pharmacology and related biomedical sciences. Her early education and research laid the groundwork for her focus on cardiovascular and cerebrovascular pharmacology. This formative phase shaped her expertise in the integration of traditional Chinese medicine (TCM) with modern pharmacological principles.

💼 PROFESSIONAL ENDEAVORS

As a Master’s Supervisor at Qingdao Medical College, Qingdao University, Dr. Zhu has become a pivotal figure in guiding students and contributing to cutting-edge research. Her dedication to academic excellence is reflected in her active leadership in national and provincial projects, fostering innovation and exploration in pharmacological sciences.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACO-ONCOLOGY

Dr. Zhu’s research delves into the regulation of mitochondria by TCM and its main components for the prevention and treatment of nerve injury. Her groundbreaking work has revealed the preventive effects and molecular mechanisms of these compounds on ischemic stroke, bridging traditional medicine with modern therapeutic approaches.

🌟 IMPACT AND INFLUENCE

Dr. Zhu’s research outputs, including more than 20 academic papers published in high-level international journals, have significantly advanced the understanding of ischemic stroke and pharmacological neuroprotection. Her work has gained recognition within the academic community for its innovation and practical applications.

📖 ACADEMIC CITATIONS

With a robust publication record, Dr. Zhu’s studies have garnered extensive citations in the global scientific community, reflecting the influence and relevance of her research. Her findings continue to inform and inspire further investigations in pharmacology and TCM integration.

🎯 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Zhu’s ongoing dedication to exploring molecular mechanisms and drug development promises a lasting impact on the field of pharmacology. Her leadership in bridging traditional and modern medicinal practices positions her as a key figure in shaping future therapeutic strategies for nerve injury and cardiovascular diseases.

🏅 OTHER SIGNIFICANT ACHIEVEMENTS

  • National and Provincial Projects: Successfully presided over three major scientific research initiatives.
  • Mentorship: Plays a crucial role in cultivating the next generation of researchers in pharmacology and TCM.
  • Cross-disciplinary Innovation: Pioneering efforts in integrating mitochondrial regulation with TCM for innovative therapeutic approaches.

Dr. Ting Zhu’s remarkable contributions underscore her commitment to advancing science and medicine through an interdisciplinary lens, promising a transformative impact on global healthcare.

🔗 CONCLUSION

Dr. Ting Zhu stands at the forefront of modern pharmacology, seamlessly integrating traditional Chinese medicine with advanced molecular research to address pressing health challenges like ischemic stroke and nerve injury. Her dedication to mentorship, impactful research, and innovative drug development underscores her significant contributions to both academic and clinical fields. As she continues to lead groundbreaking projects and inspire future generations, Dr. Zhu’s work promises to shape the future of pharmacology and redefine the role of traditional medicine in modern therapeutic practices. Her legacy is one of innovation, excellence, and transformative impact on global health.

 

📊🔬NOTABLE PUBLICATION:
  • Pharmacological Properties and Mechanisms of Notoginsenoside R1 in Ischemia-Reperfusion Injury
    • Authors: Zhu, T., Wan, Q.
    • Journal: Chinese Journal of Traumatology – English Edition
    • Year: 2023

 

  • Notoginseng Leaf Triterpenes Ameliorates Mitochondrial Oxidative Injury via the NAMPT-SIRT1/2/3 Signaling Pathways in Cerebral Ischemic Model Rats
    • Authors: Xie, W., Zhu, T., Zhou, P., Sun, G., Sun, X.
    • Journal: Journal of Ginseng Research
    • Year: 2023

 

  • DL-3-n-Butylphthalide Attenuates Cerebral Ischemia/Reperfusion Injury in Mice Through AMPK-Mediated Mitochondrial Fusion
    • Authors: Zhu, T., Dong, S., Qin, N., Shi, L., Wan, Q.
    • Journal: Frontiers in Pharmacology
    • Year: 2024

 

  • Effect of Salidroside on Neuroprotection and Psychiatric Sequelae During the COVID-19 Pandemic: A Review
    • Authors: Zhu, T., Liu, H., Gao, S., Chen, S., Xie, W.
    • Journal: Biomedicine and Pharmacotherapy
    • Year: 2024

 

  • Mechanism of Efferocytosis in Determining Ischemic Stroke Resolution—Diving into Microglia/Macrophage Functions and Therapeutic Modality
    • Authors: Xie, X.-D., Dong, S.-S., Liu, R.-J., Shi, L.-L., Zhu, T.
    • Journal: Molecular Neurobiology
    • Year: 2024

Dr. Ke Zhao | Orthopedics| Best Researcher Award

Posted on by Pencis

Dr. Ke Zhao | Orthopedics | Best Researcher Award

Wangjing Hospital of China Academy of Chinese Medical Sciences | China

Author Profile

Scopus

🩺 Dr. Ke Zhao: Resident Doctor in Orthopedics

🎓 Educational Background

  • Bachelor’s Degree (2015–2020): Hubei University of Traditional Chinese Medicine
  • Master’s Degree (2023): Hubei University of Traditional Chinese Medicine

🏆 Awards & Achievements

  • 🥉 Third Prize: Jiangsu Province “Olympic Cup” Chemistry Competition (2020)
  • 🎤 Third Prize: Hubei Province “Baisheng Lecture Theatre” Provincial Hosts (2021)
  • 🎓 National Scholarship for Postgraduate Students (2022)
  • 🌟 Hubei Province All-Round Good Student Award (2022)
  • 🎖️ Hubei Province Outstanding Graduates Award (2023)

🧑‍🔬 Research Interests

  • Intervertebral Disc Disorders
  • Osteoporosis
  • Osteonecrosis of the Femoral Head

💼 Professional Skills

  • Advanced Office Suite Proficiency
  • WeMedia Content Creation
  • Academic Research in Osteology and Traumatology

🌍 Languages

  • Proficient in English (CET-6 Certified)

🧑‍🏫 Academic Mentorship

Mentored by Dr. Li Guo Zhu, an expert in Osteology and Traumatology.

Ke Zhao is a dedicated medical professional focused on orthopaedic research and clinical excellence. With strong expertise in degenerative bone conditions and a commitment to advancing healthcare, he exemplifies the values of precision and empathy in medical practice.

✨Conclusion:

Dr. Ke Zhao is a skilled and compassionate orthopedic resident dedicated to advancing medical science and improving patient care. With a strong academic foundation, notable achievements, and a focus on conditions such as intervertebral disc disorders, osteoporosis, and osteonecrosis of the femoral head, Dr. Zhao continues to make meaningful contributions to the field of osteology and traumatology. Guided by excellence and innovation, he exemplifies a commitment to both clinical practice and research, paving the way for a promising career in orthopaedic medicine.

 

📊🔬NOTABLE PUBLICATION:
1. Lateral Locking Plate Plus Antero-Posterior Lag Screws Techniques for the Management of Posterolateral Tibial Plateau Fracture: Preliminary Clinical Results and Biomechanical Study

Authors: Gao, W., Qi, X., Zhao, K., Liu, P., Fu, D.
Journal: Archives of Orthopaedic and Trauma Surgery
Year: 2023

2. Multifunctional Gold Nanoparticles for Osteoporosis: Synthesis, Mechanism and Therapeutic Applications

Authors: Gao, W., Liang, C., Zhao, K., Hou, M., Wen, Y.
Journal: Journal of Translational Medicine
Year: 2023

3. Percutaneous Endoscopic Lumbar Discectomy for the Treatment of Recurrent Lumbar Disc Herniation: A Meta-analysis

Authors: Zhao, K., Li, L.-D., Li, T.-T., Xiong, Y.
Journal: BioMed Research International
Year: 2022

4. When Is the Optimum Time for the Initiation of Early Rehabilitative Exercise on the Postoperative Functional Recovery of Peri-Ankle Fractures? A Network Meta-Analysis

Authors: Zhao, K., Dong, S., Wang, W.
Journal: Frontiers in Surgery
Year: 2022

Dr. Na Wang | Chemotherapy | Best Researcher Award

Posted on by Pencis

Dr. Na Wang | Chemotherapy | Best Researcher Award

First Affiliated Hospital of Xi’an Jiaotong University | China

AUTHOR PROFILE

Scopus

📘 DR. NA WANG, DEPARTMENT OF RESPIRATORY AND CRITICAL CARE MEDICINE, FIRST AFFILIATED HOSPITAL OF XI’AN JIAOTONG UNIVERSITY

🏫 EARLY ACADEMIC PURSUITS

Dr. Na Wang embarked on a distinguished academic journey, laying a strong foundation in respiratory medicine and critical care. She pursued her medical degree with a focus on respiratory health, demonstrating exceptional dedication and a commitment to addressing complex medical challenges. Her postgraduate studies were marked by advanced training in pulmonology, where she honed her expertise in the diagnosis and management of respiratory diseases.

🏥 PROFESSIONAL ENDEAVORS

Currently serving at the First Affiliated Hospital of Xi’an Jiaotong University, Dr. Wang plays a pivotal role in the Department of Respiratory and Critical Care Medicine. She has contributed significantly to clinical care, focusing on Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) and the broader spectrum of critical care management. Dr. Wang is recognized for her ability to translate complex clinical scenarios into innovative therapeutic strategies, improving patient outcomes.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CHEMOTHERAPY

Dr. Wang’s research is centered on Chronic Obstructive Pulmonary Disease (COPD), particularly its acute exacerbations, which are leading causes of hospitalization and mortality worldwide. Her studies delve into:

  • The pathophysiological mechanisms underlying AECOPD.
  • Biomarker identification for early diagnosis and prognosis.
  • Innovative therapeutic approaches, including pharmacological and non-pharmacological strategies.
    Her work bridges clinical insights with translational research, contributing to the development of effective treatment modalities.

🌟 IMPACT AND INFLUENCE

Dr. Wang’s research has had a profound impact on the respiratory medicine field, especially in China. Her findings have been instrumental in shaping clinical guidelines for AECOPD management, benefiting countless patients. She is a sought-after speaker at national and international conferences, sharing her expertise on managing critical respiratory conditions.

📚 ACADEMIC CITES

With a growing body of published works, Dr. Wang has contributed extensively to peer-reviewed journals. Her articles are widely cited, reflecting the significance of her research. She continues to advance the field through collaborations with leading respiratory medicine experts and research teams globally.

🌏 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Na Wang is poised to leave an enduring legacy in respiratory and critical care medicine. Her commitment to:

  1. Advancing knowledge in AECOPD management.
  2. Mentoring future clinicians and researchers.
  3. Pioneering innovative therapeutic approaches.
    ensures that her influence will resonate for years to come. Her future contributions are expected to address emerging challenges in respiratory health and critical care, particularly in aging populations.

🛠 OTHER IMPORTANT TOPICS

💡 MULTIDISCIPLINARY APPROACH

Dr. Wang advocates for collaboration across specialties to improve patient care and advance research. Her work integrates insights from immunology, pharmacology, and critical care practices.

🎓 EDUCATION AND TRAINING INITIATIVES

Dr. Wang is actively involved in teaching and training, emphasizing evidence-based practices to cultivate the next generation of respiratory care professionals. He exemplifies excellence in respiratory and critical care medicine, with a career characterized by impactful research, clinical leadership, and an enduring commitment to improving patient outcomes.

✨CONCLUSION:

Dr. Na Wang stands as a beacon of excellence in Respiratory and Critical Care Medicine, particularly in the management and research of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). Her journey from a dedicated academic to an influential clinician and researcher reflects her unwavering commitment to advancing healthcare. Through groundbreaking research, impactful teaching, and exemplary clinical practice, Dr. Wang has significantly shaped the field, improving the lives of countless patients and setting a high standard for future contributions.

📊🔬NOTABLE PUBLICATION:
  • The association between chronic obstructive pulmonary disease and autoimmune diseases: a bidirectional Mendelian randomization study
    • Authors: Yu, X., Cheng, X., Lv, L., … Hu, T., Shi, Z.
    • Journal: Frontiers in Medicine
    • Year: 2024
  • A left pulmonary artery sling with left bronchiectasis in an adult patient: A case report and review of literature
    • Authors: Lv, L., Cheng, X., Yu, X., … Liu, J., Shi, Z.
    • Journal: Respirology Case Reports
    • Year: 2023
  • Prolonged elevated heart rate is associated with adverse outcome in severe pulmonary embolism: A retrospective study
    • Authors: Wang, G., Liu, T., Ji, W., … Hu, T., Shi, Z.
    • Journal: International Journal of Cardiology
    • Year: 2024
  • Association between prognostic nutritional index and mortality risk in patients with community-acquired pneumonia: a retrospective study
    • Authors: Wang, G., Wang, N., Liu, T., … Hu, T., Shi, Z.
    • Journal: BMC Pulmonary Medicine
    • Year: 2024
  • Development and validation of a nomogram for assessing survival in acute exacerbation of chronic obstructive pulmonary disease patients
    • Authors: Wang, N., Li, M., Wang, G., … Hu, T., Shi, Z.
    • Journal: BMC Pulmonary Medicine
    • Year: 2024

Dr. Jinyu Zhang | Hepatocellular Carcinoma | Best Researcher Award

Posted on by Pencis

Dr. Jinyu Zhang | Hepatocellular Carcinoma | Best Researcher Award

Fujian Medical University | China

AUTHOR PROFILE

Scopus

JINYU ZHANG: ACADEMIC JOURNEY AND PROFESSIONAL IMPACT

🎓EARLY ACADEMIC PURSUITS

Jinyu Zhang began their academic journey in Clinical Medicine Science at Fujian Medical University, where they pursued a rigorous undergraduate program from September 2014 to June 2019. This foundational education equipped Jinyu with a strong understanding of medical principles, diagnostics, and patient care. Their dedication to excellence during these formative years laid the groundwork for a promising career in medicine.

💼ADVANCED EDUCATION AND SPECIALIZATION

Building upon their undergraduate achievements, Jinyu Zhang pursued a Master’s degree in Surgery at Fujian Medical University from September 2019 to June 2022. This phase marked a significant transition to specialized training, allowing them to deepen their expertise in surgical techniques, patient management, and clinical research.

Currently, Jinyu is enrolled in a Doctoral program in Surgery at Fujian Medical University, which they began in September 2022. This ongoing pursuit highlights their commitment to advancing medical science and refining their clinical acumen.

🔬PROFESSIONAL ENDEAVORS

Throughout their academic career, Jinyu Zhang has shown a consistent interest in combining theoretical knowledge with practical application. Their professional endeavors include:

  • Clinical Rotations: Active participation in diverse hospital departments during their undergraduate and master’s studies to gain hands-on experience.
  • Surgical Training: Specialized focus on improving surgical outcomes and patient recovery rates.
  • Research Collaborations: Involvement in multidisciplinary projects to enhance surgical methodologies and innovate treatment strategies.

🌍CONTRIBUTIONS AND RESEARCH FOCUS ON HEPATOCELLULAR CARCINOMA

Jinyu Zhang’s research primarily focuses on:

  • Minimally Invasive Surgical Techniques: Exploring innovative approaches to reduce patient recovery time and improve procedural efficiency.
  • Post-Surgical Care Optimization: Studying ways to enhance post-operative outcomes through better patient management and intervention strategies.
  • Surgical Training and Education: Developing frameworks to improve surgical education for aspiring surgeons.

Their work bridges the gap between research and practical application, contributing to advancements in the field of surgery.

📚IMPACT AND INFLUENCE

Jinyu Zhang’s contributions to clinical medicine and surgery have started gaining recognition among peers and mentors. Their innovative ideas have the potential to shape future surgical practices and improve patient care standards. Through conference presentations and research publications, Jinyu has actively participated in disseminating knowledge to the medical community.

🔮ACADEMIC CITATIONS

Jinyu Zhang’s academic work is increasingly being cited by peers, demonstrating its relevance and impact in the field of surgery. These citations reflect the quality and applicability of their research in addressing contemporary challenges in surgical practice.

🏆LEGACY AND FUTURE CONTRIBUTIONS

As Jinyu Zhang progresses in their Doctoral studies and continues to refine their skills and research expertise, their legacy is likely to include:

  • Innovative Surgical Techniques: Introduction of new methods that could revolutionize surgical procedures.
  • Mentorship: Inspiring and guiding the next generation of medical students and researchers.
  • Collaborative Contributions: Partnering with global medical institutions to advance the field of surgery.

🌟CONCLUSION

Jinyu Zhang’s journey from a dedicated medical student to an emerging expert in surgery exemplifies a blend of academic rigor and professional ambition. Their research focus, contributions to surgical science, and commitment to patient care position them as a future leader in the field. With ongoing efforts, they are poised to leave an indelible mark on medical practice and research.

 

📊🔬NOTABLE PUBLICATION:
    1. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China
      • Authors: Chen, Y.; Liu, H.; Zhang, J.; …; Zeng, Y.; Liu, J.
      • Journal: BMC Cancer
      • Year: 2021
    1. Development and validation of nomogram to predict very early recurrence of combined hepatocellular-cholangiocarcinoma after hepatic resection: a multi-institutional study
      • Authors: Wu, Y.; Liu, H.; Zeng, J.; …; Zeng, Y.; Liu, J.
      • Journal: World Journal of Surgical Oncology
      • Year: 2022
    1. Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients
      • Authors: Lin, K.-Y.; Lin, Z.-W.; Chen, Q.-J.; …; Yang, T.; Zeng, Y.-Y.
      • Journal: Hepatology International
      • Year: 2023
    1. Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis
      • Authors: Kong, J.; Liang, X.; Zhang, J.; …; Liu, J.; Zeng, J.
      • Journal: Digestive Diseases and Sciences
      • Year: 2022
    1. Prognostic significance of three-tiered pathological classification for microvascular invasion in patients with combined hepatocellular-cholangiocarcinoma following hepatic resection
      • Authors: Wu, Y.; Liu, H.; Chen, Y.; …; Zeng, Y.; Liu, J.
      • Journal: Cancer Medicine
      • Year: 2023

Ms. Xin Xin | Cancer Biomarkers | Best Researcher Award

Posted on by Pencis

Ms. Xin Xin | Cancer Biomarkers | Best Researcher Award

Shanghai University of Traditional Chinese Medicine | China

AUTHOR PROFILE

Scopus

📚 EARLY ACADEMIC PURSUITS

Xin Xin’s academic journey is rooted in the integration of Traditional Chinese Medicine (TCM) with Western medicine, particularly focusing on reproductive health and gynecology. He obtained a Bachelor of Science in Chinese Medicine from Shandong University of Traditional Chinese Medicine. His academic foundation continued to expand as he pursued an MD in Gynecology of Traditional Chinese Medicine, further honing his expertise in reproductive diseases. Xin is currently working towards his PhD in Clinical Chinese Medicine Integrated with Western Medicine at Shanghai University of Traditional Chinese Medicine, under the guidance of Advisor Jinfu Zhang.

💼 PROFESSIONAL ENDEAVORS

Xin Xin’s professional career is centered on bridging the gap between traditional and modern medical approaches. He is particularly involved in the clinical and mechanistic research of reproductive diseases, with a primary focus on polycystic ovary syndrome (PCOS). His work aims to enhance diagnostic methods and treatment approaches through a combined understanding of TCM and Western medicine. Xin has contributed significantly to clinical studies and investigations, with his academic path guided by prominent scholars in the field, including Dr. Fang Lian and Dr. Haicui Wu during his MD program at Shandong University.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER BIOMARKERS

Xin Xin’s research is notable for its emphasis on the pathogenesis, diagnosis, and treatment of reproductive diseases, with a particular focus on PCOS. He has undertaken several groundbreaking projects, one of which explores the expression of long non-coding RNAs (lncRNA) in follicular fluid exosomes of patients with obesity and PCOS using high-throughput sequencing technology. This research represents an effort to better understand the molecular mechanisms behind PCOS and to uncover novel biomarkers for early detection and intervention.

Another area of Xin’s research explores the role of Bone Morphogenetic Protein 6 (BMP6) in regulating Pentraxin 3 expression in human granulosa lutein cells in women with PCOS. His studies are pivotal in uncovering molecular markers and pathways that could lead to more effective therapeutic strategies.

🌟 IMPACT AND INFLUENCE

Xin Xin’s work has garnered attention within the scientific community due to his innovative approach of combining traditional Chinese medicine with Western medical techniques. His research aims to contribute to the development of a more holistic and comprehensive understanding of reproductive diseases. By investigating both the molecular and clinical aspects of PCOS, Xin is pushing boundaries in reproductive health research. His work has the potential to change how clinicians approach the treatment of polycystic ovary syndrome, a condition that affects millions of women worldwide.

📑 ACADEMIC CITES

Although his research is relatively recent, Xin Xin’s work is beginning to attract attention in the academic community. His publications on the expression of lncRNAs and BMP6 in PCOS are contributing to the growing body of knowledge on this common reproductive disorder. These publications are expected to increase in citations as they influence future studies and clinical approaches. His articles, including “Exploring lncRNA expression in follicular fluid exosomes of patients with obesity and polycystic ovary syndrome” (2024), and “Bone Morphogenetic Protein 6 Induces Downregulation of Pentraxin 3 Expression in Human Granulosa Lutein Cells in Women With Polycystic Ovary Syndrome” (2024), are already making a mark in reproductive health research.

🌱 LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Xin Xin is poised to continue his impactful contributions to the field of reproductive medicine. With a focus on integrating TCM with Western medical practices, his future research may lead to the development of novel therapeutic modalities for PCOS and other reproductive diseases. He is likely to remain an influential figure in the field of gynecology, particularly in areas that explore the intersections between traditional and modern approaches to healthcare. His research has the potential to influence both clinical practices and medical education, paving the way for new, more integrated methods of treating complex reproductive health conditions.

In the coming years, Xin Xin’s work will likely expand into further clinical trials and studies, contributing to the refinement of treatments for women with PCOS, and potentially providing a more personalized and effective approach to reproductive medicine globally.

✨Conclusion:

Xin Xin’s academic and professional journey stands as a testament to the growing importance of integrating traditional and modern medical practices in addressing complex health conditions. His dedicated research in reproductive medicine, particularly focusing on polycystic ovary syndrome (PCOS), has already made valuable contributions to understanding its pathogenesis and improving diagnostic and therapeutic methods. By exploring innovative molecular mechanisms and combining high-throughput sequencing technology with traditional Chinese medicine, Xin is laying the groundwork for a more holistic approach to treating reproductive diseases.

📊🔬NOTABLE PUBLICATION:
  • Reproductive outcomes of dual trigger with combination GnRH agonist and hCG versus trigger with hCG alone in women undergoing IVF/ICSI cycles: a retrospective cohort study with propensity score matching
    • Authors: Dong, L., Lian, F., Wu, H., Yu, X., Xin, X.
    • Journal: BMC Pregnancy and Childbirth
    • Year: 2022

 

  • The effect of large follicle puncture and aspiration on the outcomes of IVF-ET in patients with asynchronized follicles under the long GnRH-a protocol: a retrospective cohort study
    • Authors: Wang, Y., Pang, C., Wu, H., Xin, X., Lian, F.
    • Journal: BMC Pregnancy and Childbirth
    • Year: 2023

 

  • Effect of human chorionic gonadotropin injection before frozen-thawed embryo transfer: A retrospective cohort study
    • Authors: Xin, X., Dong, L., Guan, L., Li, J., Lian, F.
    • Journal: Medicine (United States)
    • Year: 2023

 

  • Clinical Efficacy and Mechanism of Erzhi Tiangui Prescription in Treatment of Patients with Repeated Implantation Failure of Kidney Deficiency Syndrome Based on sPD-1 and Th17/Treg Cytokines
    • Authors: Wang, Y., Pang, C., Wu, H., Xin, X., Lian, F.
    • Journal: Chinese Journal of Experimental Traditional Medical Formulae
    • Year: 2023

 

  • Total knee arthroplasty in patients with Klippel Trenaunay syndrome and knee osteoarthritis: A case report and a literature review
    • Authors: Li, J., Lv, G., Han, Z., Xin, X.
    • Journal: Medicine (United States)
    • Year: 2024

Assoc. Prof. Dr. Huan Zhang | Nanobiotechnology | Best Researcher Award

Posted on by Pencis

Assoc. Prof. Dr. Huan Zhang | Nanobiotechnology | Best Researcher Award

Shanghai Jiao Tong University | China

Author Profile

Scopus

Google Scholar

Huan Zhang, Ph.D. 🌱🧬

Associate Professor, School of Agriculture and Biology

🧬Research Interests

Dr. Huan Zhang’s research centers on nanoscale construction and manipulation techniques that leverage nanotechnology to simulate, regulate, and monitor life processes, advancing human health and sustainable development. Key areas of focus include:

  • 🧬 Precision design and controllable self-assembly of DNA framework structures
  • 🔬 Nanoprobe design with applications in biosensing and bioimaging
  • 🧬 Nanotechnology-mediated gene editing, delivery of functional molecules, and innovative approaches to disease treatment

🎓Education and Training

  • Postdoctoral Researcher (Feb 2017 – Jul 2020): UC Berkeley, Markita Landry Lab 🌿
    Developed abiotic delivery platforms in plant systems using nanomaterials like DNA origami, carbon nanotubes, and gold nanoparticles.
  • Research Assistant (Sep 2014 – Jan 2017): Shanghai Advanced Research Institute, CAS 🧫
    Engineered nanomaterial-based sensors for cancer biomarker detection.
  • Ph.D. in Chemistry (Sep 2009 – Jul 2014): Shanghai Institute of Applied Physics, CAS
    Focused on biomedicine applications of DNA nanostructures and graphene oxide.
  • B.Sc. in Chemistry (Sep 2005 – Jul 2009): Ludong University, China

🔬Academic Activities

Dr. Zhang has presented numerous invited talks on nanotechnology in genetic engineering, including notable conferences like the International Association for Plant Biotechnology Congress and the International Conference on DNA Nanotechnology.

🏆 Honors and Awards

  • 🌟 Shanghai Pujiang Talent Award (2022-2024)
  • 🏆 National Natural Science Foundation of China Research Grant (2017-2019)
  • 🏅 Chinese Academy of Sciences Excellent Student Award (2013-2014)
  • 🎓 National Inspirational Scholarship (2008)

🏅Professional Service

  • Peer Reviewer for journals such as Nature Protocols, Advanced Science, and ACS Applied Materials & Interfaces
  • Guest Associate Editor for Plants and Frontiers in Genome Editing

✨Conclusion:

  • Dr. Huan Zhang is a distinguished researcher in nanotechnology and its applications in agriculture, biology, and medicine. With expertise in DNA framework structures, biosensing, and nanotechnology-mediated gene editing, Dr. Zhang’s work bridges foundational science and real-world applications, from innovative plant genetic engineering to advanced disease treatments. His academic journey, marked by international collaborations and recognition from prestigious organizations, underscores his contributions to advancing sustainable solutions and human health. As a dedicated educator and active contributor to scientific communities, Dr. Zhang is at the forefront of integrating nanotechnology into life sciences for a better future. 🌱🧬

     

📊🔬NOTABLE PUBLICATION:
  • Title: Nanoparticle cellular internalization is not required for RNA delivery to mature plant leaves
    Authors: Zhang, H., Goh, N.S., Wang, J.W., Park, S.-J., Landry, M.P.
    Journal: Nature Nanotechnology
    Year: 2022

 

  • Title: Gold-Nanocluster-Mediated Delivery of siRNA to Intact Plant Cells for Efficient Gene Knockdown
    Authors: Zhang, H., Cao, Y., Xu, D., Landry, M.P., Yang, P.
    Journal: Nano Letters
    Year: 2021

 

  • Title: Effects of rice root exudates on aggregation, dissolution and bioaccumulation of differently-charged Ag nanoparticles
    Authors: Yang, J., Duan, H., Wang, X., Zhang, H., Zhang, Z.
    Journal: RSC Advances
    Year: 2022

 

  • Title: Plant biomacromolecule delivery methods in the 21st century
    Authors: Rustgi, S., Naveed, S., Windham, J., Zhang, H., Demirer, G.S.
    Journal: Frontiers in Genome Editing
    Year: 2022

 

  • Title: Imaging tools for plant nanobiotechnology
    Authors: Zhao, B., Luo, Z., Zhang, H., Zhang, H.
    Journal: Frontiers in Genome Editing
    Year: 2022

Prof. Boheng Zhang | Liver cancer | Best Researcher Award

Posted on by Pencis

Prof. Boheng Zhang | Liver cancer | Best Researcher Award

Zhongshan Hospital, Fudan University | China

Author Profile

Scopus

💼Professor Zhang Boheng 🎓🧬

Title:

Party Secretary and Executive Director of the Hepatocellular Carcinoma Department at Xiamen Hospital, affiliated with Zhongshan Hospital, Fudan University.

🎓Education and Training:

  • Doctor of Medicine (1996-1999): Fudan University
  • Master of Medicine (Clinical Epidemiology) (1992-1996): The University of Newcastle, Australia
  • Bachelor of Medicine (1983-1989): Fudan University School of Public Health
  • Advanced Training (2001-2002): Monash Medical School, Australia, and The Alfred Hospital

👨‍⚕️Professional Experience🏥:

  • Resident Physician (1989-1995): Zhongshan Hospital, Fudan University
  • Main Physician and Assistant Researcher (1995-2000): Zhongshan Hospital, Fudan University
  • Associate Researcher (2000-2009): Zhongshan Hospital, Fudan University
  • Doctoral Supervisor (2012-present): Zhongshan Hospital, Fudan University
  • Vice President and Executive Director (2017-2023): Hepatocellular Carcinoma Department, Xiamen Hospital
  • Party Secretary and Executive Director (2023-present): Hepatocellular Carcinoma Department, Xiamen Hospital

🏆Awards:

  1. Standard Academic Contribution Award for Primary Liver Cancer in China (2024)
  2. Top Ten Medical Contribution Experts of “Driving Forward the Industry” (2023)
  3. Advanced Worker in Fujian Health System (2021)
  4. Innovative Entrepreneur of Xiamen Special Economic Zone (2021), celebrating its 40th anniversary
  5. Leading Talent in Medical Disciplines of Xiamen City, Fujian Province (2021)

📚Key Publications:

  1. Early Detection of Cancer, co-edited with Yang Binghui, Fudan University Press, 2003
  2. Liver Cancer in China, co-authored with Yang Binghui, in Screening for Common Malignancies: A Practical Guide, The Humana Press Inc., 2001
  3. Clinical Epidemiology, co-edited, Jiangsu Science & Technology Press, 2018

🔬Research Projects:

  1. Immunosuppressive Microenvironment in Intrahepatic Cholangiocarcinoma, National Natural Science Foundation of Fujian, 2022-2025, Principal Investigator
  2. Precision Diagnosis and Treatment System for Hepatocellular Carcinoma, Key Science and Technology Project of Xiamen, 2019-2023
  3. Innovation Project for High-Risk Hepatocellular Carcinoma Patients, Haicang District Health Bureau, Xiamen, ongoing
  4. Effects of Shuangyouyin on Residual Cancer Cells Post-Chemotherapy, National Natural Science Foundation of China, 2010, Completed

🌐Professional Affiliations:

  • Chairman of the Sixth Committee, Evidence-Based Medicine Professional Committee, China Medical Association
  • Vice Chairman, Fifth Committee, Evidence-Based Medicine Professional Committee, China Medical Association
  • Member, Fifth Council, China Medical Association
  • Member, Eighth Committee, Clinical Epidemiology and Evidence-Based Medicine Branch, Chinese Medical Association
  • Vice Chairman, Shanghai Cancer Association Committee on Cancer Prevention and Screening

Prof. Zhang Boheng is a respected figure in oncology, dedicated to advancing liver cancer diagnostics, treatment, and prevention. His leadership in evidence-based medicine and clinical epidemiology supports his extensive work on hepatocellular carcinoma and contributes significantly to public health.

✨Conclusion:

  • Professor Zhang Boheng stands out as a prominent leader in the field of oncology, particularly in hepatocellular carcinoma research and treatment. His extensive education and training, coupled with decades of clinical and academic experience, have positioned him as an influential figure in advancing cancer care in China. Through his leadership roles and active participation in professional committees, he promotes evidence-based practices and innovative approaches in medicine.

📊🔬NOTABLE PUBLICATION:
  • Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
    • Authors: Zhou, J., Sun, H., Wang, Z., Dong, J., Fan, J.
    • Journal: Liver Cancer
    • Year: 2023

 

  • Development of the Scientific, Transparent and Applicable Rankings (STAR) tool for clinical practice guidelines
    • Authors: Yang, N., Liu, H., Zhao, W., Chen, Y., Wei, J.
    • Journal: Chinese Medical Journal
    • Year: 2023

 

  • Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study
    • Authors: Xu, B., Dong, S.-Y., Bai, X.-L., Rao, S.-X., Sun, H.-C.
    • Journal: Liver Cancer
    • Year: 2023

 

  • A Novel Myeloid Cell Marker Genes Related Signature Can Indicate Immune Infiltration and Predict Prognosis of Hepatocellular Carcinoma: Integrated Analysis of Bulk and Single-Cell RNA Sequencing
    • Authors: Zheng, S.-S., Wu, Y.-F., Zhang, B.-H., Huang, C., Xue, T.-C.
    • Journal: Frontiers in Molecular Biosciences
    • Year: 2023

 

  • Peripheral Lymphocytes in Primary Liver Cancers: Elevated NK and CD8+ T Cells and Dysregulated Selenium Metabolism
    • Authors: Zhou, C., Lu, Z., Sun, B., Wang, Z., Qiu, S.-J.
    • Journal: Biomolecules
    • Year: 2024